ArticleCancer immunology, immunotherapy : CII2021

Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer.

Yehui Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.